Overview

Dr. Iman Abdulaziz Al-Saleh is a senior environmental health scientist with more than three decades of experience in human biomonitoring, toxicology, and exposure science. She has led numerous national and international research projects investigating exposure to toxic metals, endocrine-disrupting chemicals, pesticides, and air pollutants, with particular focus on women, children, and other vulnerable populations. Her work bridges laboratory science, epidemiology, and clinical research, addressing health outcomes such as neurodevelopment, reproductive health, metabolic disorders, and cancer risk. Dr. Al-Saleh has published extensively in high-impact international journals and serves on editorial boards of leading scientific journals. She has also held several senior leadership and administrative roles at King Faisal Specialist Hospital & Research Centre, contributing to research governance, capacity building, and strategic planning.

Fields of Expertise

Human biomonitoring of environmental chemicals.

Toxic metals exposure (lead, mercury, cadmium, arsenic).

Endocrine-disrupting chemicals (phthalates, BPA, parabens).

Environmental epidemiology.

Maternal, neonatal, and child health.

Genotoxicity and oxidative stress assessment.

Risk assessment and exposure science.

Career Background

Dr. Al-Saleh has spent most of her career at King Faisal Specialist Hospital & Research Centre, where she established and led the Environmental Health Program and held several senior leadership positions, including Director of Research Affairs and Acting Chair of Clinical Studies and Empirical Ethics. Her research portfolio includes large-scale cohort, case-control, and longitudinal studies funded by national and international agencies, focusing on environmental exposures and their health impacts across the life course. She has supervised and mentored researchers, served on multiple institutional committees, and actively contributes to scientific publishing as an editor and peer reviewer for leading international journals.
Beta Version